Downregulation of hsa‐miR‐548d‐3p and overexpression of HOXA9 in diffuse large B‐cell lymphoma patients and the risk of R‐CHOP chemotherapy resistance and disease progression

Introduction Routine categorization of DLBCL patients into GCB and non‐GCB groups by Hans' criteria could not accurately predict chemotherapy resistance and disease progression in patients treated with standard R‐CHOP therapy. There is a need to identify better biomarker predictors to enhance a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of laboratory hematology 2022-10, Vol.44 (5), p.907-917
Hauptverfasser:	Ting, Choo‐Yuen, Tan, Soo‐Yong, Gan, Gin‐Gin, Zain, Shamsul‐Mohd, Pung, Yuh‐Fen, Ong, Diana Bee‐Lan, Bee, Ping‐Chong
Format:	Artikel
Sprache:	eng
Schlagworte:	Apoptosis B-cell lymphoma Chemoresistance Chemotherapy disease progression Disease resistance lymphoma large B‐cell diffuse microRNA mRNA expression miRNA mRNA p53 Protein resistance R‐CHOP chemotherapy Signal transduction
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!